Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants.

NCT06200844 is registered in ClinicalTrials.gov with Bharat Biotech International Limited as lead sponsor.

NCT NCT06200844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06200844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants.
Lead sponsor
Bharat Biotech International Limited
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 7, 2023
Completion date
July 31, 2026
Enrollment
5,800 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

rotavirus infection of children